TI
MAZE

Trexquant Investment’s Maze Therapeutics MAZE Stock Holding History

Trexquant Investment’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Buy
+81,668
New +$2.14M 0.01% 1111
2026
Q1 		– Sell
-52,459
Closed -$2.17M – 2117
2025
Q4 		$2.17M Buy
+52,459
New +$1.8M 0.02% 966

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Trexquant Investment's MAZE Position: Q2 2026 in Review

Trexquant Investment opened a new position in Maze Therapeutics (MAZE) in Q2 2026: 81,668 shares worth $2.44M. The stake represents 0.01% of the portfolio and ranks #1111 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in MAZE as recently as Q4 2025.

Trexquant Investment first reported a position in MAZE in Q4 2025 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Trexquant Investment held 81,668 shares of Maze Therapeutics worth $2.44M as of Q2 2026.
  • Maze Therapeutics was a new Trexquant Investment position in Q2 2026.
  • Maze Therapeutics made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1111 holding.
  • Trexquant Investment first reported a position in Maze Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.